Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
Go back to Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 2.77 +0.07 (2.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $9.09 | |||
| Open | $2.81 | 52 Week Low | $4.02 | |||
| Day High | $2.82 | P/E | N/A | |||
| Day Low | $2.70 | EPS | $-0.05 | |||
| Volume | 19,008 | |||||
